News_Anti-Acid Therapies in Idiopathic Pulmonary Fibrosis: Premature to Dismiss?
By: Louise E Crowley, Andrew Wilson, David R Thickett
We’re delighted to announce that a letter highlighting the clinical need and importance of the TIPAL trial, titled Anti-Acid Therapies in Idiopathic Pulmonary Fibrosis: Premature to Dismiss?, has now been published in the American Journal of Respiratory and Critical Care Medicine.
Congratulations to authors Louise E Crowley, Andrew Wilson and David R Thickett!
Related Articles
Perfectionist leaders may drive employees to work while ill
Employees under pressure to meet exceptionally high standards are more likely to experience conflict at home and work while unwell, according to a University of East Anglia study.
Read more
New UEA spinout Nascent Therapeutics secures investment to advance revolutionary treatment for age-related conditions
A spinout company from the University of East Anglia (UEA) is developing a revolutionary new approach to treating neurodegenerative diseases, cancer, and other age-related conditions.
Read more
Scientists uncover shared biology behind profound fatigue in five major illnesses
A shared biological secret that helps explain chronic exhaustion in conditions including long Covid and PTSD has been discovered by researchers at the University of East Anglia and Oxford BioDynamics.
Read more